CA9 and neoplasm: CAIX inhibitors negatively affect cancer cell viability and migration, as well as collagen destruction and invasion, and hinder both tumour formation and metastic growth in murine models, suggesting that increased expression and activity of CAIX in a cancer will adversly affect progression and prognosis.